Figur8 has filed a notice of an exempt offering of securities to raise $24,566,788.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Figur8 is raising $24,566,788.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Nan-Wei Gong played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Figur8
FIGUR8 has developed the first musculoskeletal diagnostics decision support system of its kind that can accurately pinpoint the source and severity of an injury while showing real-time recovery visibility to improve musculoskeletal health at every point of care from injury through full recovery. FIGUR8 began as a collaboration between MIT scientists, Massachusetts General Hospital Orthopaedics and the Boston Red Sox, in search of a better way to diagnose and treat injuries. The result was a state-of-the-art sports lab providing objective, actionable data around MSK function. FIGUR8 has now adapted that technology for use at any point of care.
To learn more about Figur8, visit http://figur8tech.com/
Contact:
Nan-Wei Gong, Chief Executive Officer
617-202-6750
https://www.linkedin.com/in/nan-wei-gong-6693a520/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.